Key Record Dates
ClinicalTrials.gov Identifier: | NCT02864992 |
---|---|
Brief Title: | Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION) |
First Submitted : | July 29, 2016 |
First Submitted that Met QC Criteria : | August 9, 2016 |
First Posted : | August 12, 2016 (Estimate) |
Results First Submitted : | May 15, 2023 |
Results First Submitted that Met QC Criteria : | May 15, 2023 |
Results First Posted : | June 9, 2023 |
Last Update Submitted that Met QC Criteria : | May 15, 2023 |
Last Update Posted : | June 9, 2023 |